Ryan Specialty (NYSE:RYAN) Stock Rating Lowered by Wolfe Research

Ryan Specialty (NYSE:RYAN) was downgraded by analysts at Wolfe Research from an “outperform” rating to a “peer perform” rating in a research report issued to clients and investors on Monday, MarketBeat Ratings reports.

Several other analysts have also recently commented on RYAN. Citigroup raised their target price on Ryan Specialty from $49.00 to $52.00 and gave the company a “neutral” rating in a research report on Wednesday, February 28th. Keefe, Bruyette & Woods raised their price target on Ryan Specialty from $56.00 to $62.00 and gave the company an “outperform” rating in a report on Wednesday, April 10th. JPMorgan Chase & Co. upped their price objective on shares of Ryan Specialty from $47.00 to $49.00 and gave the stock an “underweight” rating in a report on Monday, April 8th. JMP Securities reiterated a “market perform” rating on shares of Ryan Specialty in a research report on Monday, April 15th. Finally, Wells Fargo & Company boosted their price target on shares of Ryan Specialty from $57.00 to $58.00 and gave the stock an “overweight” rating in a research report on Thursday, April 11th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $54.25.

Ryan Specialty Stock Performance

Shares of RYAN opened at $52.18 on Monday. The company has a debt-to-equity ratio of 1.98, a quick ratio of 1.16 and a current ratio of 1.16. Ryan Specialty has a 1 year low of $39.44 and a 1 year high of $56.51. The firm has a fifty day moving average of $52.65 and a 200-day moving average of $47.13. The company has a market cap of $13.58 billion, a price-to-earnings ratio of 98.45 and a beta of 0.58.

Ryan Specialty (NYSE:RYAN) last posted its earnings results on Thursday, May 2nd. The company reported $0.35 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.35. Ryan Specialty had a net margin of 9.15% and a return on equity of 46.11%. The firm had revenue of $552.00 million during the quarter, compared to analyst estimates of $549.06 million. During the same period in the previous year, the business posted $0.26 EPS. Ryan Specialty’s revenue was up 20.6% on a year-over-year basis. As a group, equities analysts anticipate that Ryan Specialty will post 1.77 earnings per share for the current year.

Institutional Trading of Ryan Specialty

A number of hedge funds and other institutional investors have recently made changes to their positions in RYAN. PNC Financial Services Group Inc. grew its position in Ryan Specialty by 192.0% in the third quarter. PNC Financial Services Group Inc. now owns 549 shares of the company’s stock worth $27,000 after buying an additional 361 shares during the last quarter. First Horizon Advisors Inc. grew its holdings in shares of Ryan Specialty by 27.6% in the 3rd quarter. First Horizon Advisors Inc. now owns 2,409 shares of the company’s stock worth $117,000 after acquiring an additional 521 shares during the last quarter. Alliance Wealth Advisors LLC UT raised its position in shares of Ryan Specialty by 3.1% during the fourth quarter. Alliance Wealth Advisors LLC UT now owns 19,187 shares of the company’s stock worth $825,000 after purchasing an additional 581 shares during the period. Precision Wealth Strategies LLC lifted its holdings in shares of Ryan Specialty by 4.1% during the first quarter. Precision Wealth Strategies LLC now owns 15,774 shares of the company’s stock valued at $875,000 after purchasing an additional 617 shares during the last quarter. Finally, Intelligent Financial Strategies acquired a new position in shares of Ryan Specialty in the 1st quarter valued at $44,000. 84.82% of the stock is currently owned by institutional investors.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.